Faraz Ali - 16 May 2025 Form 4 Insider Report for Tenaya Therapeutics, Inc. (TNYA)

Role: Chief Executive Officer, Director
Signature: /s/ Jennifer Drimmer Rokovich, Attorney-in-Fact
Issuer symbol: TNYA
Transactions as of: 16 May 2025
Net transactions value: -$1,412
Form type: 4
Filing time: 16 May 2025, 19:07:01 UTC
Previous filing: 10 Mar 2025
Next filing: 18 Aug 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Ali Faraz	Chief Executive Officer, Director	C/O TENAYA THERAPEUTICS, INC., 171 OYSTER POINT BLVD., 5TH FLOOR, SOUTH SAN FRANCISCO	/s/ Jennifer Drimmer Rokovich, Attorney-in-Fact	16 May 2025	0001667937

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TNYA	Common Stock	Sale	$1,412	-3,189	-0.99%	$0.4427	317,325	16 May 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 6, 2025.
F2	Includes 259,568 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.